Bioarctic Ab Stock Performance

BRCTF Stock   33.14  0.00  0.00%   
BioArctic has a performance score of 9 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.25, which signifies not very significant fluctuations relative to the market. As returns on the market increase, BioArctic's returns are expected to increase less than the market. However, during the bear market, the loss of holding BioArctic is expected to be smaller as well. BioArctic AB right now shows a risk of 1.27%. Please confirm BioArctic AB variance, potential upside, as well as the relationship between the Potential Upside and day median price , to decide if BioArctic AB will be following its price patterns.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in BioArctic AB are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, BioArctic may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
Begin Period Cash Flow999.9 M
Total Cashflows From Investing Activities-4.4 M
  

BioArctic Relative Risk vs. Return Landscape

If you would invest  3,025  in BioArctic AB on November 19, 2025 and sell it today you would earn a total of  289.00  from holding BioArctic AB or generate 9.55% return on investment over 90 days. BioArctic AB is currently producing 0.1576% returns and takes up 1.2698% volatility of returns over 90 trading days. Put another way, 11% of traded pink sheets are less volatile than BioArctic, and 97% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon BioArctic is expected to generate 1.68 times more return on investment than the market. However, the company is 1.68 times more volatile than its market benchmark. It trades about 0.12 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.16 per unit of risk.

BioArctic Target Price Odds to finish over Current Price

The tendency of BioArctic Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 33.14 90 days 33.14 
about 57.55
Based on a normal probability distribution, the odds of BioArctic to move above the current price in 90 days from now is about 57.55 (This BioArctic AB probability density function shows the probability of BioArctic Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon BioArctic has a beta of 0.25 suggesting as returns on the market go up, BioArctic average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding BioArctic AB will be expected to be much smaller as well. Additionally BioArctic AB has an alpha of 0.2532, implying that it can generate a 0.25 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   BioArctic Price Density   
       Price  

Predictive Modules for BioArctic

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BioArctic AB. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of BioArctic's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
31.8733.1434.41
Details
Intrinsic
Valuation
LowRealHigh
29.8338.8940.16
Details

BioArctic Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. BioArctic is not an exception. The market had few large corrections towards the BioArctic's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold BioArctic AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of BioArctic within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.25
β
Beta against Dow Jones0.25
σ
Overall volatility
2.10
Ir
Information ratio 0.13

BioArctic Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BioArctic for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BioArctic AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
BioArctic AB has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 23.15 M. Net Loss for the year was (119.79 M) with profit before overhead, payroll, taxes, and interest of 155.53 M.
BioArctic generates negative cash flow from operations
About 48.0% of the company shares are held by company insiders

BioArctic Fundamentals Growth

BioArctic Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of BioArctic, and BioArctic fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BioArctic Pink Sheet performance.

About BioArctic Performance

By analyzing BioArctic's fundamental ratios, stakeholders can gain valuable insights into BioArctic's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if BioArctic has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if BioArctic has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.

Things to note about BioArctic AB performance evaluation

Checking the ongoing alerts about BioArctic for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for BioArctic AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
BioArctic AB has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 23.15 M. Net Loss for the year was (119.79 M) with profit before overhead, payroll, taxes, and interest of 155.53 M.
BioArctic generates negative cash flow from operations
About 48.0% of the company shares are held by company insiders
Evaluating BioArctic's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate BioArctic's pink sheet performance include:
  • Analyzing BioArctic's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BioArctic's stock is overvalued or undervalued compared to its peers.
  • Examining BioArctic's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating BioArctic's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BioArctic's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of BioArctic's pink sheet. These opinions can provide insight into BioArctic's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating BioArctic's pink sheet performance is not an exact science, and many factors can impact BioArctic's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for BioArctic Pink Sheet analysis

When running BioArctic's price analysis, check to measure BioArctic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioArctic is operating at the current time. Most of BioArctic's value examination focuses on studying past and present price action to predict the probability of BioArctic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioArctic's price. Additionally, you may evaluate how the addition of BioArctic to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing